BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Phase I
Galectin Therapeutics Announces First Patient Dosed In Second Cohort Of Phase 1 Trial Of GR-MD-02 For NASH With Advanced Fibrosis 4/17/2014  More...
Agios Pharmaceuticals (AGIO) Initiates Phase 1 Study Of AG-348, A First-in-class PKR Activator, For Pyruvate Kinase Deficiency 4/17/2014  More...
StemCells Inc. (STEM) Completes Enrollment In Spinal Cord Injury Trial 4/17/2014  More...
Dicerna Pharmaceuticals (DRNA) Initiates Phase 1 Study Of DCR-MYC In Patients With Solid Tumors And Hematological Malignancies 4/17/2014  More...
XBiotech USA, Inc. Announces Phase I/II Study Results In Lancet 4/17/2014  More...
One Of A Kind Trial To Test 14 AstraZeneca PLC (AZN), Pfizer Inc. (PFE) Drugs At The Same Time 4/17/2014  More...
Karyopharm Therapeutics (KPTI) Announces Initiation Of A Phase 1 Study Of Decitabine (Dacogen®) And Selinexor (KPT-330) In Acute Myeloid Leukemia (AML) 4/16/2014  More...
Cleveland Biolabs Inc. (CBLI) Announces The Successful Completion Of A Phase 1 Study Of CBL0102 4/16/2014  More...
Bay Area's Igenica, Inc. Follows Genentech (RHHBY) Into Antibody-Linked Cancer Drugs 4/16/2014  More...
Critical Pharmaceuticals Limited, The University of Nottingham And Nottingham University Hospitals NHS Trust Starts First Phase I Clinical Trial On A Nano-Enabled Intranasal Teriparatide For The Treatment Of Osteoporosis 4/15/2014  More...
ProTrials Research, Inc. Completes Significant Phase III Clinical Trial For New Ophthalmic Disease Treatment 4/14/2014  More...
Long-Term Outcomes From Cytori Cell Therapy Trial For Heart Failure Published In American Heart Journal 4/14/2014  More...
Precision Biologics’ NEO-102 Continues To Show Encouraging Results In Pancreatic And Colorectal Cancer Patients 4/11/2014  More...
Vectura Group plc (VEC.L): FAVOLIR Regulatory Update 4/11/2014  More...
TetraLogic Pharmaceuticals (TLOG) Announces Publication Of Structural Characterization Of Birinapant 4/9/2014  More...
Prothena Corporation plc Release: First Human Dosed In Phase 1 Study Of PRX002 For Treatment Of Parkinson's Disease 4/9/2014  More...
ImmunoGen, Inc. (IMGN) Announces First Clinical Findings With Refined Dosing Strategy For IMGN853 4/9/2014  More...
Whoa. Agios Pharmaceuticals (AGIO)'s Experimental Cancer Drug Makes Cancer Undetectable In Three Patients 4/9/2014  More...
Merrimack Pharmaceuticals Inc. (MACK) Announces Preliminary Data From Pilot Diagnostic Imaging Study Of MM-398 4/8/2014  More...
Capstone Therapeutics (CAPS) Announces Initiation Of Dosing For AEM-28 Phase 1 Human Clinical Trial In LDL/Non-HDL Cholesterol Reduction 4/8/2014  More...
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Presentation Of Positive Results From Ongoing MD Anderson-Sponsored Trial Of Vosaroxin In AML And High-Risk MDS 4/8/2014  More...
Newron Pharmaceuticals (NWRN) Release: New Results With NW-3509 Presented At SIRS Conference 4/8/2014  More...
Xenetic Biosciences Announces Positive Phase 1 Clinical Data For Pulmoxen™ For Treatment Of Cystic Fibrosis 4/7/2014  More...
Idenix Pharmaceuticals, Inc. (IDIX) Announces Promising Clinical Data And Continued Progress In Nucleotide Prodrug Development Programs For The Treatment Of Hepatitis C 4/7/2014  More...
Deciphera Pharmaceuticals Announces Initiation Of Phase 1 Cancer Trial For LY3009120 4/7/2014  More...
Oxford BioMedica PLC (OXB.L) Completes Patient Recruitment Into Retinostat® Phase I Trial 4/7/2014  More...
Novartis AG (NVS) Shows Off A Strong Pipeline Of 19 New Compounds At American Association for Cancer Research 4/4/2014  More...
Kamada Ltd. (KMDA.TA) Announces U.S. Proof-Of-Concept Study With Glassia® For Graft-Versus-Host Disease 4/3/2014  More...
Novaliq GmbH Announces Launch Of A Phase 1 Study Following US And European Patent Approval Of Cyclasol® (Cyclosporin) Eye Drops 4/3/2014  More...
Caprion (CAPR) To Present Immune Response Results From Phase 1 Study In Ovarian Cancer Patients At 2014 American Association for Cancer Research Annual Meeting 4/3/2014  More...
Pozen, Inc. (POZN) Submits Final Study Report For PA8140/PA32540 Phase 1 Study On Schedule 4/2/2014  More...
CryoLife, Inc. (CRY) Receives FDA Approval to Begin Clinical Trials For PerClot® In The U.S. 4/2/2014  More...
AREVA Med LLC Phase 1 Clinical Trial Expanded in U.S. 4/1/2014  More...
First Cohort Results In Galectin Therapeutics' Phase 1 Trial Reveal Biomarker Evidence Of Therapeutic Effect On Fibrosis And Inflammation In Nash With Advanced Fibrosis 4/1/2014  More...
Curis, Inc. (CRIS) Announces Removal Of FDA Partial Clinical Hold On CUDC-427 3/31/2014  More...
Innate Pharma (IPH.PA ) : Start Of Cohort Expansion Of Phase I Trial With Lirilumab And Nivolumab In Selected Solid Tumors 3/31/2014  More...
e-Therapeutics plc Reports Positive Interim Results From UK Phase Ia Trial Of ETS2101 (Dexanabinol) In A Variety Of Solid Tumours 3/31/2014  More...
ProLynx Publishes Results Of Ultralong Half-Life PEG-SN38 Pro-Drug With Lower Intestinal Toxicity 3/28/2014  More...
Anavex Life Sciences Corp. (AVXL.OB) Reports Predicted Clinical Effect Of Both ANAVEX 2-73 And ANAVEX PLUS In A Humanized Cortical Cognitive Model For Alzheimer's Disease 3/28/2014  More...
bluebird bio Announces First Patient Transplanted In Phase 1/2 Northstar Study For The Treatment Of Beta-Thalassemia 3/27/2014  More...
SAGE Therapeutics Initiates Phase 1/2 Trial Of SAGE-547 In Status Epilepticus 3/27/2014  More...
Clovis Oncology (CLVS)’s CO-1686 Demonstrates Compelling Clinical Activity And Progression-Free Survival (PFS) In Updated Phase 1 Study Results In Patients With Non-Small Cell Lung Cancer (NSCLC) 3/27/2014  More...
Ultragenyx Pharmaceuticals Announces Preliminary Data From Phase 1/2 Study Of Recombinant Human Beta-Glucuronidase In Mucopolysaccharidosis 7 3/27/2014  More...
Threshold Pharmaceuticals, Inc. (THLD)' Partner Merck KGaA (MKGAF.PK), Darmstadt, Germany Initiates Phase 1 Dose Escalation Study Of TH-302 In Combination With Gemcitabine And Nab-paclitaxel (Abraxane(R)) In Pancreatic Cancer 3/27/2014  More...
AM-Pharma Holding BV Announces Positive Phase I Data On recAP, For Acute Kidney Injury 3/26/2014  More...
e-Therapeutics plc Announces Recruitment Resumes Into UK Phase I ETS2101 Cancer Trial 3/26/2014  More...
Ability Pharmaceuticals Initiates Clinical Trial With Its Dual mTORC1/C2 Inhibitor ABTL0812 In Patients With Lung And Pancreatic Cancer 3/26/2014  More...
Cellceutix (CTIX) Initiates Clinical Trial Of Prurisol As New Treatment For Psoriasis 3/25/2014  More...
Galectin Therapeutics To Announce Results From First Cohort Of Phase 1 Clinical Trial In Fatty Liver Disease 3/25/2014  More...
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Introduction Of The New Lot Of Lintuzumab Into The Clinic 3/25/2014  More...
Agios Pharmaceuticals Enrolls First Patient In Phase 1 Study Of AG-120 In Advanced Solid Tumors With An IDH1 Mutation 3/24/2014  More...
Scancell: 8mg Higher Dose SCIB1 Study On Track 3/21/2014  More...
Adocia Confirms Positive Clinical Results For Its Biochaperone® Combo, A Combination Of Long-Acting Insulin Glargine And Fast-Acting Insulin Lispro 3/20/2014  More...
Hua Medicine Reports Strong Results For Early Diabetes Drug Trial 3/20/2014  More...
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 1 Study Of ISIS-ANGPTL3 Rx To Treat Hyperlipidemia 3/19/2014  More...
VaxInnate Corporation Begins Phase I Clinical Trial To Evaluate Quadrivalent Vaccine For Prevention Of Seasonal Flu 3/19/2014  More...
Agios Pharmaceuticals Announces Enrollment Of First Patient In Phase 1 Study Of AG-120 In Advanced Hematologic Malignancies With An IDH1 Mutation 3/19/2014  More...
Seventh Cohort Underway In Cellceutix (CTIX) Clinical Trial Of Kevetrin For Solid Tumors 3/19/2014  More...
Repros Therapeutics Inc. (RPRX) Allowed To Conduct Phase 1 And 2 Clinical Studies Of Low Dose Oral Proellex® In The Treatment Of Uterine Fibroids And Endometriosis 3/18/2014  More...
Cerulean Pharma Inc. Announces First Patient Dosed In Phase 1b/2 Trial Of CRLX101 In Combination With Chemotherapy And Radiation In Neoadjuvant Rectal Cancer 3/18/2014  More...
Igenica, Inc. Enrolls First Patient In Phase 1 Study Of IGN523 In Acute Myeloid Leukemia 3/18/2014  More...
GW Pharmaceuticals Provides Update on Cannabinoid Pipeline 3/17/2014  More...
Repros Therapeutics Inc. (RPRX) Allowed To Conduct Phase 1 And 2 Clinical Studies Of Low Dose Oral Proellex® In The Treatment Of Uterine Fibroids And Endometriosis 3/17/2014  More...
Final Results Of NeuralStem Inc. Phase I Stem Cell Trial In Amyotrophic Lateral Sclerosis Published In Annals of Neurology 3/17/2014  More...
VG Life Sciences, Inc. (VGLS) Reports On Clinical Outcomes In Phase I Cancer Study 3/17/2014  More...
Presentation At Annual Society Of Surgical Oncology Meeting Updates Progress In Investigator-Sponsored Phase 1/2 Trial Of Peregrine Pharmaceuticals, Inc. (PPHM)'s Bavituximab In Combination With Sorafenib In Liver Cancer 3/17/2014  More...
VG Life Sciences, Inc. (VGLS) Reports On Clinical Outcomes In Phase 1 Cancer Study 3/14/2014  More...
Rexahn Pharmaceuticals, Inc. (RNN) Announces Initial Results From Phase I Trial Of Supinoxintm (RX-5902) For Solid Cancer Tumors 3/11/2014  More...
Betagenon AB: First Time In Man-AMPK Activator O304 3/10/2014  More...
Fibrotech Announces Positive Phase Ia Results For Anti-Fibrotic FT011 3/10/2014  More...
Contract Research Organization WCCT Global Announces Successful Management Of Multi-Site Asthma Clinical Trial 3/6/2014  More...
Verastem, Inc. (VSTM) Reports Data From Phase 1 Study Of VS-6063 (defactinib) In Japanese Patients 3/6/2014  More...
Tekmira Pharmaceuticals Corporation Receives Fast Track Designation From FDA For Its Anti-Ebola Viral Therapeutic 3/6/2014  More...
Bay Area's Sangamo BioSciences, Inc. (SGMO) Surges As Gene Editing Tech Make Cells Repel HIV 3/6/2014  More...
Regulus Therapeutics, Inc. Commences Dosing RG-101 In Healthy Volunteers In Phase I Study 3/5/2014  More...
Anavex Life Sciences Corp. (AVXL.OB): Research Report Reveals Cardioprotective Action Of Sigma-1 Receptor Agonists 3/4/2014  More...
Bristol-Myers Squibb Company (BMY)'s Experimental Drug Helps Body Fight Advanced Melanoma 3/4/2014  More...
TapImmune Inc. (TPIV) Releases Positive Interim Data On Phase I Clinical Trial In HER2/Neu+ Breast Cancer 3/3/2014  More...
Intra-Cellular Therapies, Inc. Announces Initiation Of Phase I/II Clinical Trial For ITI-007 In Healthy Geriatric Subjects And Patients With Dementia, Including Alzheimer's Disease 3/3/2014  More...
Biocryst Pharmaceuticals (BCRX) Presents BCX4161 Phase 1 Trial And Kallikrein Inhibition Assay Results 3/3/2014  More...
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL) Receives Orphan Status For Lead Drug Candidate Pracinostat For Treatment Of Acute Myeloid Leukemia 2/28/2014  More...
Karyopharm Therapeutics (KPTI) Announces Initiation Of An Investigator Sponsored Phase 1 Dose Escalation Study Of Its Lead Drug Candidate Selinexor (KPT-330) In Singapore 2/27/2014  More...
AtheroNova Inc. (AHRO.OB) Announces Preliminary Positive Phase 1 Clinical Data From Lead Drug AHRO-001, A Potential Treatment For Atherosclerosis 2/27/2014  More...
Immune Design Corporation Announces Treatment Of First Patient In Phase 1 Clinical Trial Of ID-G305 Cancer Immunotherapy Agent 2/27/2014  More...
QLT Inc. (QLTI) Announces Positive Preliminary Results From Phase 1b Retreatment Trial Of QLT091001 In Subjects With Leber Congenital Amaurosis And Retinitis Pigmentosa Due To Mutations In LRAT Or RPE65 2/27/2014  More...
Seattle Genetics, Inc. (SGEN) Highlights ADCETRIS® (Brentuximab Vedotin) Clinical Data At The 2014 Bone Marrow Transplant Tandem Meetings 2/27/2014  More...
Triphase Receives FDA Orphan Drug Designation For Marizomib In Multiple Myeloma 2/27/2014  More...
Adocia Announces Preliminary Positive Clinical Results For Its Combination Of Long-Acting Insulin Glargine And Fast-Acting Insulin Analog Lispro, Biochaperone® Combo 2/27/2014  More...
Dyax Corp. (DYAX) Announces Positive Results From Phase 1a Clinical Trial Of DX-2930 2/26/2014  More...
DelMar Pharmaceuticals Provides Update On VAL-083 Glioblastoma Clinical Trial 2/26/2014  More...
Calithera Biosciences, Inc. Initiates Three Phase 1 Trials With First-In-Class Glutaminase Inhibitor CB-839 In Patients With Advanced Solid And Hematological Cancers 2/24/2014  More...
Ignyta Announces Preliminary Data From RXDX-101 Phase 1 Clinical Trial 2/21/2014  More...
Epizyme (EPZM) Announces Publication Of Preclinical Data Demonstrating Clinical Candidate EPZ-6438 As Potent And Selective Inhibitor Of EZH2 In Genetically Defined Non-Hodgkin Lymphoma 2/21/2014  More...
OncoMed Pharmaceuticals, Inc. (OMED) Commences Third Phase 1b Clinical Trial For OMP-54F28 (Fzd8-Fc) With Carboplatin And Paclitaxel In Ovarian Cancer 2/20/2014  More...
Cempra Initiates Solithromycin Pediatric Program 2/20/2014  More...
VentiRx Pharmaceuticals, Inc. Presents Phase 1 Data On VTX-2337 At 2014 Multidisciplinary Head And Neck Cancer Symposia 2/20/2014  More...
Oncothyreon Inc. (ONTY) And Array BioPharma, Inc. (ARRY) Announce Initiation Of Phase 1b Trial Of ONT-380 In Combination With TDM-1 In Patients With Metastatic HER2+ Breast Cancer 2/20/2014  More...
OncoMed Pharmaceuticals, Inc. (OMED) Initiates Second Phase 1b Clinical Trial For OMP-54F28 (Fzd8-Fc) With Sorafenib (Nexavar®) In Hepatocellular Cancer 2/18/2014  More...
SanBio, Inc. Announces The First Public Presentation Of Data From Its On-Going Human Clinical Trial Of Cell Therapy For Chronic Stroke Disability 2/14/2014  More...
Biodel Inc. (BIOD) Announces Plans To Advance BIOD-531 Based On Positive Clinical Trial Results 2/13/2014  More...
GANYMED Pharmaceuticals AG's IMAB027 Enters Phase I/II Clinical Trial For Ovarian Cancer 2/12/2014  More...
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Publication Of Data Demonstrating Efficacy Of AEOL 10150 In Animal Model Of Lung Radiation Exposure; Models Developed For Pivotal Efficacy Studies 2/11/2014  More...
Nanobiotix: Sees Clinical Advance In Soft Tissue Sarcoma Pilot Trial With Lead Product, NBTXR3 Market Development Plan Outlined For Earlier Potential Launch In 2016 2/11/2014  More...
AVAX Technologies, Inc. (AVXT) Announces Expansion Of Clinical Study With Autologous Ovarian Cancer Vaccine (Ovax®) 2/11/2014  More...
PDS Biotechnology Corporation Announces Treatment Of First Patient With PDS0101 Based On The Novel Versamune™ Cancer Immunotherapy Platform In A Phase 1 Clinical Trial 2/10/2014  More...
Omeros Corporation (OMER) Reports Additional Positive Phase 1 Clinical Data For OMS824 For The Treatment Of Cognitive Disorders 2/10/2014  More...
Protalex, Inc. (PRTX) Announces Interim Findings From U.S. Phase 1(b) Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients 2/10/2014  More...
e-Therapeutics plc Begins Phase I Study Of Oral Formulation Of Anti-Cancer Compound ETS2101 With Healthy Volunteers 2/10/2014  More...
Phase 1 Clinical Trial Begins For Malaria Vaccine Candidate Based On iBio, Inc. (IBIO)'s Proprietary Technology 2/10/2014  More...
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT) Announces Positive Safety Results From Phase I Clinical Study Of Marburg Drug Candidate 2/10/2014  More...
Trevena, Inc. (TRVN) Initiates Clinical Development Of TRV734, A Novel Biased Ligand For Moderate To Severe Pain 2/5/2014  More...
Fraunhofer USA Center for Molecular Biotechnology Begins Clinical Trial Of New Malaria Vaccine Approach 2/5/2014  More...
THERAVECTYS Finalizes The Recruitment Of Patients For The Phase I/II Clinical Trial Of Its Anti-HIV Therapeutic Vaccine Candidate 2/5/2014  More...
Relypsa, Inc. (RLYP) Completes Enrollment Of Phase 1 Onset-Of-Action Study For Patiromer 2/5/2014  More...
Sigma-Tau Pharmaceuticals Announces First Patient Dosed In Phase 1/2 Clinical Trial Of STP206 For Prevention Of Necrotizing Enterocolitis In Very Low Birth Weight Premature Infants 2/4/2014  More...
TRACON Pharmaceuticals, Inc. Initiates Phase 1b Study Of TRC105 In Patients With Advanced Soft Tissue Sarcoma 2/4/2014  More...
Galectin Therapeutics And Providence Portland Medical Center Receive OK From FDA To Proceed With Phase 1B Clinical Trial In Metastatic Melanoma 2/4/2014  More...
Bionomics Limited (BMICY.PK) Release: BNC105 Phase I/II Trial Achieves A High Response Rate In Ovarian Cancer 2/3/2014  More...
Admedus Herpes Interim Phase I Results 2/3/2014  More...
Orion Corporation Release: The Androgen Receptor Inhibitor ODM-201 - New Insights In The Treatment Of Prostate Cancer 2/3/2014  More...
U.S. Navy Approves Start Of CEL-SCI (CVM)’s Phase I Trial For Treatment Of Anal Warts In HIV/HPV Co-Infected Patients 2/3/2014  More...
Omeros Corporation (OMER) Announces Positive Data After Completion Of Dosing In Phase 1 Clinical Trial With OMS721 2/3/2014  More...
Oncothyreon Inc. (ONTY) And Array BioPharma, Inc. (ARRY) Announce Initiation Of Phase 1b Trial Of ONT-380 In Combination With Capecitabine And/Or Trastuzumab In Patients With Metastatic HER2+ Breast Cancer 2/3/2014  More...
TherapeuticsMD, Inc.  (TXMD) Reports Positive PK Study Results For Its Estradiol Vaginal Capsule Vagicap™ (TX 12-004-HR) For Treatment Of Vulvar Vaginal Atrophy (VVA) 1/28/2014  More...
Immune Design Corporation Announces Treatment Of First Patient In Phase 1 Clinical Trial Of ID-G100, An Investigational Immuno-Oncology Agent 1/27/2014  More...
Infinity Pharmaceuticals Inc. (INFI) Reports Phase 1 Data Of IPI-145 At Sixth Annual T-Cell Lymphoma Forum 1/24/2014  More...
Inhibitor Program Acquired For Promising Research Of Rare Disease, Friedreich's Ataxia 1/24/2014  More...
e-Therapeutics plc Temporary Halts Recruitment Into ETS2101 Cancer Trials 1/24/2014  More...
Merrimack Pharmaceuticals Inc. (MACK) Initiates Phase 1 Clinical Study Of MM-398 In Combination With Cyclophosphamide For Pediatric Solid Tumors 1/23/2014  More...
Anavex Life Sciences Corp. (AVXL.OB) Release: Sigma-1 Receptor Implicated In Cell Survival Of Rare Neurodegenerative Diseases - Expanding The Opportunity For Application Of ANAVEX PLUS In Rare Diseases 1/23/2014  More...
Aeolus Pharmaceuticals Inc. (AOLS.OB) Receives Orphan Drug Designation For AEOL 10150 From U.S. FDA 1/23/2014  More...
Karyopharm Therapeutics (KPTI) Presents Clinical Data On Selinexor (KPT-330) In Colorectal Cancer From Ongoing Phase 1 Study And Preclinical Data On Novel PAK4 Inhibitors At American Society of Clinical Oncology 2014 Gastrointestinal Cancers Symposium 1/22/2014  More...
Arno Therapeutics Enrolls First Patient In A Phase I Trial To Evaluate Lead Compound Onapristone In Progesterone Receptor Positive Solid Tumors 1/22/2014  More...
Cortice Biosciences Announces Enrollment Of A Clinical Trial Targeting Tau Dysfunction In Mild-To-Moderate Alzheimer's Disease 1/22/2014  More...
Alnylam Pharmaceuticals (ALNY) Initiates Phase 1 Clinical Trial With ALN-AT3, a Subcutaneously Administered RNAi Therapeutic Targeting Antithrombin (AT) In Development For The Treatment Of Hemophilia And Rare Bleeding Disorders (RBD) 1/22/2014  More...
Pluristem Therapeutics (PSTI)' Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints 1/21/2014  More...
Cortice Biosciences Announces Enrollment Of A Clinical Trial Targeting Tau Dysfunction In Mild-To-Moderate Alzheimer's Disease 1/21/2014  More...
Kolltan Pharmaceuticals Inc. Initiates Phase 1 Study Of KTN3379, A Dual-Mechanism Anti-Erbb3 Monoclonal Antibody 1/21/2014  More...
Sunshine Biopharma, Inc. Targets Pancreatic Cancer As Second Indication For Clinical Trials Of Adva-27a Compound 1/21/2014  More...
Boehringer Ingelheim Corporation Switches Type 2 Diabetes Candidate In Zealand Pharma  (ZEAL.CO) Collaboration 1/21/2014  More...
Pluristem Therapeutics (PSTI) Shares Slump A Day Before Phase 1/2 Study Results Are Released 1/20/2014  More...
OncoMed Pharmaceuticals, Inc. (OMED) Presents Data From Demcizumab Phase 1b Clinical Study In Pancreatic Cancer At The 2014 Gastrointestinal Cancers Symposium 1/17/2014  More...
OncoMed Pharmaceuticals, Inc. (OMED) Presents Data From The Phase 1b Portion Of The ALPINE Clinical Study Of OMP-59R5 In Pancreatic Cancer At The 2014 Gastrointestinal Cancers Symposium 1/17/2014  More...
Faron Pharmaceuticals Release: Promising New Treatment For Life Threatening Acute Respiratory Distress Syndrome (ARDS) 1/15/2014  More...
Nektar Therapeutics (CA) (NKTR) Release: First Subjects Dosed In Phase 1 Clinical Study Of NKTR-171, A New Peripherally-Restricted Sodium Channel Blocker To Treat Neuropathic Pain 1/14/2014  More...
Tekmira Pharmaceuticals Corporation Doses First Subject In Human Clinical Trial Of TKM-Ebola 1/14/2014  More...
GeoVax Labs Inc. (GOVX.OB) Announces Preliminary Top-Line Results For Phase 1 Therapeutic Vaccine Trial In HIV-Infected Patients 1/13/2014  More...
Tengion Inc. Announces Continued Clinical Progress In Its Two Lead Programs 1/13/2014  More...
OncoMed Pharmaceuticals, Inc. (OMED) Initiates First Phase 1b Clinical Trial Of OMP-54F28 (Fzd8-Fc) With Nab-Paclitaxel (Abraxane®) And Gemcitabine In Pancreatic Cancer 1/13/2014  More...
Galectin Therapeutics Announces Completion Of Enrollment In First Cohort Of Phase 1 Trial Of GR-MD-02 In Fatty Liver Disease With Advanced Fibrosis 1/13/2014  More...
FDA Grants QIDP Designation To The Medicines Company (MDCO)'s Investigational Antibiotic Carbavance 1/13/2014  More...
Enanta Pharmaceuticals, Inc. Initiates Phase 1 Study Of MRSA Infection Candidate EDP-788 1/13/2014  More...
BioLineRx Ltd. Announces Regulatory Submission For Novel Stem Cell Mobilization Treatment 1/13/2014  More...
First Patient Treated In NeuralStem Inc. China Stem Cell Trial To Treat Stroke Motor Deficits 1/13/2014  More...
Oxford BioMedica PLC (OXB.L) Announces Publication Of ProSavin® Phase I/II Study in The Lancet 1/10/2014  More...
StemCells Inc. (STEM) Expands Phase 1/2 Spinal Cord Injury Trial To North America 1/10/2014  More...
First Patient In Cohort 4 Receives Infusion Of Senesco Technologies, Inc. (SNT)’s Therapeutic Candidate, SNS01-T, For The Treatment Of Multiple Myeloma And Non-Hodgkins Lymphoma In Phase 1b/2a Clinical Trial 1/9/2014  More...
Vaxart, Inc.’s Oral H1N1 Influenza Vaccine Generates Protective Immunity 1/9/2014  More...
Aerie Pharmaceuticals, Inc. (AERI) Reports Positive Results For Lead Candidate AR-13324 In Normotensive Individuals 1/9/2014  More...
Rexahn Pharmaceuticals, Inc. (RNN) Initiates Phase 1b Clinical Trial Of RX-3117 For Treatment Of Solid Tumors 1/8/2014  More...
Adheron Therapeutics Announces Favorable Phase 1 Clinical Trial Results 1/8/2014  More...
Neumedicines Inc.’ Study Shows HemaMax, Not Neupogen (G-CSF), Improves Survival Outcomes Following Lethal Irradiation 1/8/2014  More...
BrainStorm Cell Therapeutics Inc. Says Stem Cells Helped 75-Year Old Patient With ALS And MG 1/7/2014  More...
e-Therapeutics plc Provides Update On ETS2101 Phase I Trial In Brain Cancer 1/7/2014  More...
Results Of Pluristem Therapeutics (PSTI)'s Phase 1/2 Muscle Injury Trial To Be Announced On January 21, 2014 1/6/2014  More...
ImmunoCellular Therapeutics, Ltd (IMUC) Announces First Patient Receives Vaccine In Phase I Trial Of Cancer Vaccine ICT-121 In Recurrent Glioblastoma 12/27/2013  More...
ARTES Biotechnology Release: TA101 GOCLIN European Funded Project For The Development Of An Innovative Product For The Treatment Of Rheumatoid Arthritis – 1,7M€ Total Budget 12/23/2013  More...
Alnylam Pharmaceuticals (ALNY) and Collaborators Publish Novel Method for Detection of Tissue-Specific, RNAi-Mediated Gene Silencing 12/20/2013  More...
Coronado Biosciences (CNDO) Says Drug That Failed In Crohn's Disease May Work In Autism 12/19/2013  More...
Blaze Bioscience Inc. Announces Initiation Of First-In-Human Phase 1 Clinical Study Of BLZ-100 12/19/2013  More...
BeiGene Co.,Ltd Enrolls First Patient In Phase 1 Study Of BGB-283 12/19/2013  More...
BioLineRx Ltd. Enters Clinic With Novel Treatment For Celiac Disease 12/19/2013  More...
NewLink Genetics Launches Phase 1 Clinical Trial Of Its HyperAcute™ Renal Immunotherapy In Patients With Metastatic Renal Cell Cancer 12/19/2013  More...
FDA Grants Orphan Drug Designation To Omeros Corporation (OMER)' OMS721 For Complement-Mediated Thrombotic Microangiopathies 12/18/2013  More...
California Stem Cell, Inc. Announces Completion Of Phase I Cancer Stem Cell Clinical Trial For Hepatocellular Carcinoma 12/18/2013  More...
Retrophin, LLC Unveils New Clinical Development Candidate RE-034, An ACTH Analog 12/18/2013  More...
Vical Incorporated (VICL) Announces Initiation Of Phase 1/2 Trial Of A Therapeutic HSV-2 Vaccine For Genital Herpes 12/17/2013  More...
BerGenBio AS Release: Data Highlights BGB324 As A Potential Novel Treatment Option For Drug Resistant Chronic Myeloid Leukemia 12/17/2013  More...
Drawbridge Pharmaceuticals Initiates Clinical Trial For Phaxan™ 12/16/2013  More...
Cellular Biomedicine Group Announces Completion Of Patient Treatment For Phase I Clinical Trial For Liver Cancer 12/16/2013  More...
Tekmira Pharmaceuticals Corporation's Anti-Ebola Program To Proceed In Clinical Study With More Potent Formulation 12/13/2013  More...
Merrimack Pharmaceuticals Inc. (MACK) Announces Encouraging Clinical Data From Expanded Phase 1 Study Of MM-302 For The Treatment Of Advanced HER2-Positive Breast Cancer 12/13/2013  More...
VG Life Sciences, Inc. (VGLS) Update On Phase I Cancer Study 12/13/2013  More...
Endocyte, Inc. (ECYT) Enrolls First Patient In Phase 1 Study For The Small Molecule Drug Conjugate EC1456, A Folate-Targeted Tubulysin Conjugate In Advanced Solid Tumors 12/12/2013  More...
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Initiation Of An Investigator-Sponsored Trial Evaluating Vosaroxin In Combination With Azacitidine In MDS 12/10/2013  More...
MorphoSys AG Announces Additional Clinical Trial of MOR208 12/10/2013  More...
Cornerstone Pharmaceuticals, Inc. Presents Updated Phase I Data For CPI-613 At 2013 American Society of Hematology Annual Meeting 12/10/2013  More...
Curis, Inc. (CRIS) Reports Cudc-907 Preliminary Data From THE Ongoing Phase 1 Trial AT American Society of Hematology 2013 Annual Meeting 12/10/2013  More...
Adaptimmune Ltd. Announces Interim Results From A Phase I/II Trial Of Engineered T Cells Targeting Cancer Testis Antigens In Multiple Myeloma 12/10/2013  More...
Emergent BioSolutions (EBS)' Otlertuzumab (TRU-016) Shows Positive Results In Combination With Rituximab In People With CLL 12/10/2013  More...
Acetylon Pharmaceuticals Highlights Positive Interim Phase 1b Clinical Data Of Ricolinostat (ACY-1215) In Multiple Myeloma At American Society of Hematology Annual Meeting 12/10/2013  More...
NKT Therapeutics Inc. Reports First Clinical Results With Anti-iNKT Antibody In Patients With Sickle Cell Disease 12/10/2013  More...
Kite Pharma, Inc.'s Lead Program With The National Cancer Institute Demonstrates Positive Results In Patients With Aggressive Non-Hodgkin's Lymphoma 12/10/2013  More...
Verastem, Inc. (VSTM) Initiates Clinical Trial Of Dual mTOR/PI3K Inhibitor 12/10/2013  More...
Janssen Research & Development Release: Ibrutinib Data Published In The Lancet Oncology Suggest A Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65 12/10/2013  More...
NewLink Genetics Initiates Phase 1 Clinical Trial Of NLG919, A Novel Immune Checkpoint Inhibitor For Cancer Immunotherapy 12/10/2013  More...
KaloBios Pharmaceuticals, Inc. Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies With KB004, An Anti-EphA3 Monoclonal Antibody 12/10/2013  More...
Upsher-Smith Laboratories Presents New Data On The PK Equivalence Of USL255 (Extended-Release Topiramate) When Sprinkled On Food Or Swallowed Intact 12/10/2013  More...
AbbVie (ABBV) Leukemia Drug Impresses In Early-Stage Trial 12/10/2013  More...
TG Therapeutics, Inc. (MHA) Announces Presentation Of Encouraging Clinical Activity Of TGR-1202 In An Ongoing Multi-Center Phase I Clinical Study 12/9/2013  More...





 

//-->